Skip Nav

Clinical Guidelines Portal

Updated Perinatal Guideline

Updates were made to the Perinatal Guideline on January 22, 2013, January 29, 2013 and April 3, 2013. For an explanation of the updates, please see the correction notice.

Search

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

Zalcitabine (HIVID, ddC)

(Last updated:9/14/2011; last reviewed:7/31/2012)

 Zalcitabine (HIVID, ddC) is no longer available in the United States.